Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC2A9 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
mRNA | MAGED4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | INPP4B | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | EXOSC9 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
mRNA | NANOS1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
mRNA | SAP30 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | NBPF1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
mRNA | RNPEP | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
mRNA | NPL | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
mRNA | RAB27A | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |